Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
300
datasets available to search
ShareScore release 0.9.0
Dataset results
300 results for “aromatase”
Randomized Trial of Fulvestrant With or Without Dasatinib in Men and Postmenopausal Women Who Have Hormone Receptor-positive Advanced Breast Cancer Previously Treated With an Aromatase Inhibitor
ClinicalTrials.gov study NCT00754325. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Aromatase Inhibitor Therapy With or Without Fulvestrant for the Treatment of HR Positive Metastatic Breast Cancer With an ERS1 Activating Mutation, the INTERACT Study
ClinicalTrials.gov study NCT04256941. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Pilot Study of Cyclobenzaprine for Treatment of Sleep Disturbance in Aromatase Inhibitor-treated Breast Cancer Patients
ClinicalTrials.gov study NCT01921296. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Effect of Intravaginal Prasterone on Symptoms of VVA in Women Under Treatment With an Aromatase Inhibitor for Breast Cancer
ClinicalTrials.gov study NCT03740945. IPD Sharing: NO. Countries: 0. Publications: 8.
Influence of Aromatase Inhibitors and GnRH Analogs to Treat Uterine Leiomyoma by Vaginal Hysterectomy
ClinicalTrials.gov study NCT01280045. IPD Sharing: Not stated. Countries: 0. Publications: 1.
Celecoxib Inhibition of Aromatase Expression and Inflammation in Adipose Tissue of Obese Postmenopausal Women
ClinicalTrials.gov study NCT01901679. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of BMS-754807 Combined With Letrozole or BMS-754807 Alone in Patients With Hormone Receptor-Positive Breast Cancer and Resistance to Non-Steroidal Aromatase Inhibitors
ClinicalTrials.gov study NCT01225172. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Fulvestrant and Ipatasertib for Advanced HER-2 Negative and Estrogen Receptor Positive (ER+) Breast Cancer Following Progression on First Line CDK 4/6 Inhibitor and Aromatase Inhibitor
ClinicalTrials.gov study NCT04650581. IPD Sharing: NO. Countries: 3. Publications: 0.
Impact of Adjuvant Treatment With Aromatase Inhibitor on Sleep Disturbances in Postmenopausal Women With Endocrine Responsive Early Breast Cancer
ClinicalTrials.gov study NCT02166281. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of GDC-0810 Versus Fulvestrant in Postmenopausal Women With Advanced or Metastatic Breast Cancer Resistant to Aromatase Inhibitor (AI) Therapy
ClinicalTrials.gov study NCT02569801. IPD Sharing: Not stated. Countries: 6. Publications: 0.
Zoledronic Acid in Aromatase Inhibitor Induced Musculoskeletal Symptoms
ClinicalTrials.gov study NCT01194440. IPD Sharing: NO. Countries: 1. Publications: 0.
Serum Estradiol Levels In Postmenopausal Women With Breast Cancer Receiving Adjuvant Aromatase Inhibitors and Vaginal Estrogen
ClinicalTrials.gov study NCT00984399. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Evaluation of Blood/Imaging Based Biomarkers, Aromatase Inhibitor Induced Musculoskeletal Syndrome
ClinicalTrials.gov study NCT03665077. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Glucosamine and Chondroitin for Aromatase Inhibitor Induced Joint Symptoms in Women With Breast Cancer
ClinicalTrials.gov study NCT00691678. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Study of the Effect of the Addition of SNDX-275 (Entinostat) to Continued Aromatase Inhibitor (AI) Therapy in Postmenopausal Women With ER+ Breast Cancer Whose Disease is Progressing
ClinicalTrials.gov study NCT00828854. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Aromatase Inhibitors in the Treatment of Male Infertility
ClinicalTrials.gov study NCT00440180. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Observational Study of Bone Complications in People With Post-menopausal Breast Cancer Who Have Stopped Treatment With Denosumab and Aromatase Inhibitors
ClinicalTrials.gov study NCT05590949. IPD Sharing: YES. Countries: 1. Publications: 0.
A Study to Evaluate the Efficacy and Safety of Herceptin® (Trastuzumab) in Combination With Arimidex® (Anastrozole) an Aromatase Inhibitor Compared to Arimidex® Alone in Patients With Metastatic Breas
ClinicalTrials.gov study NCT00022672. IPD Sharing: Not stated. Countries: 26. Publications: 0.
Sorafenib and Fulvestrant in Treating Patients With Locally Advanced or Metastatic Breast Cancer That Did Not Respond to Aromatase Inhibitor Therapy
ClinicalTrials.gov study NCT00722072. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Aromatase Inhibitor Host Factors Study
ClinicalTrials.gov study NCT01669343. IPD Sharing: YES. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.